Family Medicine Doctors in Weaverville, CA Accepting Medicare

4 Family Medicine doctors found. Showing 1 - 4

Dr. Daniel H Mcelheran, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 60 B Easter Avenue, Weaverville, CA 96093 Phone: 530-623-4186    Fax: 530-623-4397

Donald E. Krouse, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 560 Main St, Weaverville, CA 96093 Phone: 530-623-3735    Fax: 530-623-1196

Ms. Shannon Marie Spiller, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 60 Easter Ave, Weaverville, CA 96093 Phone: 530-623-4186    Fax: 530-623-4397

Randall J Meredith, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 31 Easter Ave, Weaverville, CA 96093 Phone: 530-623-4186    Fax: 530-623-0067

News Archive

Report cards, disclosures readied or deleted on hospital infections in some states

After several years of delay, Illinois has begun posting hospital infection data on its 'hospital report card' website, including facilities in the greater St. Louis area. State officials say the website — www.healthcarereportcard.illinois.gov — will benefit not only the consumer but also the health care industry. … So far, Illinois reports rates for only central line associated bloodstream infections in hospital intensive care units that occurred last year.

Molecular profiling helps cancer patients survive

Cancer patients can survive longer under treatments based on their individual genetic profiles, according to a nationwide study released jointly today by Phoenix-area healthcare organizations.

Doubts cast over aromatherapy in new study

According to new research while aromatherapy has a positive effect on mood it does not offer any other health benefits.

Results of Phase III clinical trial of HIV vaccine released

A Phase III clinical trial involving more than 16,000 adult volunteers in Thailand has demonstrated that an investigational HIV vaccine regimen was safe and modestly effective in preventing HIV infection. According to final results released by the trial sponsor, the U.S. Army Surgeon General, the prime boost combination of ALVAC(R)( )HIV and AIDSVAX(R) B/E( )lowered the rate of HIV infection by 31.2% compared with placebo.

NeuroTherapeutics Pharma closes $43 million Series B financing round

NeuroTherapeutics Pharma, Inc. (NTP), a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders, announced today that it closed a $43 million Series B financing. New investors include Fidelity Biosciences, MPM Capital and SR One, who co-led the transaction, and Pfizer, Inc. Existing investors Novo Ventures and Thomas McNerney & Partners also participated in the round.

Read more Medical News

› Verified 8 days ago